» Articles » PMID: 34063748

High Fat Activates O-GlcNAcylation and Affects AMPK/ACC Pathway to Regulate Lipid Metabolism

Overview
Journal Nutrients
Date 2021 Jun 2
PMID 34063748
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A high-fat diet often leads to excessive fat deposition and adversely affects the organism. However, the mechanism of liver fat deposition induced by high fat is still unclear. Therefore, this study aimed at acetyl-CoA carboxylase (ACC) to explore the mechanism of excessive liver deposition induced by high fat. In the present study, the ORF of ACC1 and ACC2 were cloned and characterized. Meanwhile, the mRNA and protein of ACC1 and ACC2 were increased in liver fed with a high-fat diet (HFD) or in hepatocytes incubated with oleic acid (OA). The phosphorylation of ACC was also decreased in hepatocytes incubated with OA. Moreover, AICAR dramatically improved the phosphorylation of ACC, and OA significantly inhibited the phosphorylation of the AMPK/ACC pathway. Further experiments showed that OA increased global O-GlcNAcylation and agonist of O-GlcNAcylation significantly inhibited the phosphorylation of AMPK and ACC. Importantly, the disorder of lipid metabolism caused by HFD or OA could be rescued by treating CP-640186, the dual inhibitor of ACC1 and ACC2. These observations suggested that high fat may activate O-GlcNAcylation and affect the AMPK/ACC pathway to regulate lipid synthesis, and also emphasized the importance of the role of ACC in lipid homeostasis.

Citing Articles

Potato protein hydrolysate (PPH902) exerts anti-lipogenesis and lipolysis-promoting effect by inhibiting adipogenesis in 3T3-L1 adipocytes.

Baskaran R, Chen Y, Chang C, Kuo H, Liang C, Abomughaid M 3 Biotech. 2025; 15(4):83.

PMID: 40078570 PMC: 11893942. DOI: 10.1007/s13205-025-04238-0.


Chestnut ( S. et Z.) inner shell-A by-product promotes anti-obesity by regulating adipogenesis and lipogenesis-related genes and the AMPK/ACC signaling pathway in high-fat diet-induced obese mice.

Park Y, Lee H, Shin D, Hwang H, Yang H, Kim M Heliyon. 2025; 11(4):e42586.

PMID: 40066053 PMC: 11891676. DOI: 10.1016/j.heliyon.2025.e42586.


Nanotechnology-driven EGCG: bridging antioxidant and therapeutic roles in metabolic and cancer pathways.

Esmaeili Z, Shavali Gilani P, Khosravani M, Motamedi M, Maleknejad S, Adabi M Nanomedicine (Lond). 2025; 20(6):621-636.

PMID: 39924937 PMC: 11881875. DOI: 10.1080/17435889.2025.2462521.


In silico design and computational screening of berberine derivatives for potential antidiabetic activity through allosteric activation of the AMPK pathway.

Kakoti B, Zothantluanga J, Deka K, Halder R, Roy D In Silico Pharmacol. 2025; 13(1):12.

PMID: 39780772 PMC: 11704122. DOI: 10.1007/s40203-024-00295-0.


From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease.

Xu W, Zhu Y, Wang S, Liu J, Li H Antioxidants (Basel). 2025; 13(12.

PMID: 39765868 PMC: 11727289. DOI: 10.3390/antiox13121540.


References
1.
Janevski M, Ratnayake S, Siljanovski S, McGlynn M, Cameron-Smith D, Lewandowski P . Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat. Food Funct. 2011; 3(2):141-9. DOI: 10.1039/c1fo10111k. View

2.
Jump D, Torres-Gonzalez M, Olson L . Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharmacol. 2010; 81(5):649-60. PMC: 3031740. DOI: 10.1016/j.bcp.2010.12.014. View

3.
Goedeke L, Bates J, Vatner D, Perry R, Wang T, Ramirez R . Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents. Hepatology. 2018; 68(6):2197-2211. PMC: 6251774. DOI: 10.1002/hep.30097. View

4.
Lizcano J, Goransson O, Toth R, Deak M, Morrice N, Boudeau J . LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004; 23(4):833-43. PMC: 381014. DOI: 10.1038/sj.emboj.7600110. View

5.
Abu-Elheiga L, Oh W, Kordari P, Wakil S . Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci U S A. 2003; 100(18):10207-12. PMC: 193540. DOI: 10.1073/pnas.1733877100. View